Macy, M., Cash, T., Pinto, N., Pressey, J. G., Szalontay, L., Furman, W. L., Bukowinski, A., Foster, J. H., Friedman, G. K., HaDuong, J., Fox, E., Weigel, B. J., Grevel, J., Huang, F., Phelps, C., Childs, B. H., Chung, J., Chaturvedi, S., Schulz, A., & DuBois, S. G. (2022). Phase I dose-escalation study of the pan-PI3 K inhibitor copanlisib in children and adolescents with relapsed/refractory solid tumors. European Journal of Cancer, 174, S28–S29. https://doi.org/10.1016/s0959-8049(22)00878-4